% | $
Quotes you view appear here for quick access.

Regeneron Pharmaceuticals, Inc. Message Board

  • gs88gs88 gs88gs88 Aug 3, 2014 10:54 PM Flag

    PCSK9 inhibitor

    Greetings. I am a primary care physician. I attended a conference recently and it looks like the PCSK9 inhibitors will get market share especially for the 10% of patients that are statin intolerant. They seem to be very well tolerated and lower LDL by about 70%. . I'm looking to purchase some shares of either REGN or SNY. I'm looking for advise REGN vs SNY (I realize I'm on the REGN board so the bias likely will be to REGN). I already own several biotech stocks and SNY has a decent dividend. Can others give me some reasons REGN vs SNY? (or should I own a bit of both if I like this class of meds). I appreciate the thoughts....

512.24+1.16(+0.23%)Jul 6 4:00 PMEDT